Genetron Holdings Total Revenue

Genetron Holdings (GTH) currently reports a total revenue of $650M as of December 2022. That compares with $530M in the prior-year period — up 22.3% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Genetron Holdings's total revenue history and peer comparisons.

Genetron Holdings's total revenue increased from $530M to $650M — a 22.3% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genetron Holdings's total revenue of $650M is lower than the Healthcare sector average of $110B. That is roughly 99.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Genetron Holdings reported $650M in total revenue as of December 2022. That compares with $530M in the prior-year period — up 22.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $650M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Genetron Holdings, and consider following GTH for alerts when major investors trade the stock.